News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
45,250 Results
Type
Article (4126)
Company Profile (22)
Press Release (41101)
Section
Business (12145)
Career Advice (35)
Deals (1477)
Drug Delivery (13)
Drug Development (5608)
Employer Resources (5)
FDA (675)
Job Trends (1036)
News (18475)
Policy (1397)
Tag
2025 Best Places to Work (3)
2026 Best Places to Work (4)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Standard (3)
2027 Pharm Country Standard (2)
40 Under 40 (1)
Academia (393)
Accelerated approval (7)
Adcomms (1)
Allergies (7)
Alliances (4443)
ALS (14)
Alzheimer's disease (46)
Antibody-drug conjugate (ADC) (121)
Approvals (724)
Artificial intelligence (91)
ASCO (62)
Autoimmune disease (19)
Automation (19)
Bankruptcy (13)
Best Places to Work (938)
BIO (3)
Biologics (8)
BIOSECURE Act (1)
Biosimilars (3)
BioSpace Insights (7)
Biotechnology (11)
Bispecific (4)
Bladder cancer (31)
Brain cancer (17)
Breast cancer (133)
Cancer (1168)
Cardiovascular disease (25)
Career advice (35)
CAR-T (45)
CDMO (18)
Cell therapy (106)
Cervical cancer (2)
Clinical research (4697)
Collaboration (276)
Company closure (1)
Compensation (51)
Complete response letters (1)
COVID-19 (187)
CRISPR (46)
C-suite (80)
Cystic fibrosis (25)
Data (1085)
Depression (1)
Dermatology (4)
Diabetes (12)
Diagnostics (1728)
Digital health (3)
Diversity (1)
Drug discovery (49)
Drug pricing (2)
Drug shortages (1)
Duchenne muscular dystrophy (18)
Earnings (3741)
Employer branding (2)
Employer resources (5)
ESMO (85)
Events (6770)
Executive appointments (67)
Eye disease (2)
FDA (927)
Frontotemporal dementia (2)
Funding (156)
Gene editing (107)
Generative AI (5)
Gene therapy (116)
GLP-1 (27)
Government (169)
Guidances (20)
Healthcare (865)
Hematology (24)
HIV (35)
Huntington's disease (9)
IgA nephropathy (5)
Immunology and inflammation (9)
Immuno-oncology (12)
Indications (20)
Infectious disease (225)
Inflammatory bowel disease (8)
Influenza (6)
Intellectual property (26)
Interviews (2)
IPO (649)
Job creations (127)
Job search strategy (32)
JPM (4)
Kidney disease (7)
Labor market (2)
Layoffs (21)
Legal (245)
Licensing (2)
Liver cancer (16)
Longevity (9)
Lung cancer (141)
Lymphoma (73)
Machine learning (8)
Management (1)
Manufacturing (135)
Marketing (2)
MASH (6)
Medical device (317)
Medtech (317)
Melanoma (21)
Mergers & acquisitions (915)
Metabolic disorders (28)
mRNA (52)
Multiple sclerosis (9)
Multispecific (1)
Netherlands (4)
Neurodegenerative disease (20)
Neuropsychiatric disorders (1)
Neuroscience (114)
NextGen: Class of 2026 (317)
Non-profit (203)
Now hiring (4)
Obesity (12)
Opinion (17)
Ovarian cancer (71)
Pain (4)
Pancreatic cancer (54)
Parkinson's disease (12)
Partnered (6)
Patents (44)
Patient recruitment (56)
Patient selection (6)
Peanut (2)
People (2865)
Peptides (1)
Pharmaceutical (6)
Phase 1 (1874)
Phase 2 (2241)
Phase 3 (1340)
Pipeline (1068)
Policy (5)
Postmarket research (113)
Preclinical (1026)
Press Release (30)
Prostate cancer (60)
Radioligand (1)
Radiopharmaceuticals (28)
Rare diseases (124)
Real estate (268)
Recruiting (3)
Regenerative medicine (4)
Regulatory (1342)
Reports (5)
Research institute (375)
Resumes & cover letters (6)
Rett syndrome (1)
RNA editing (10)
RSV (2)
Schizophrenia (4)
Series A (18)
Series B (15)
Series C (1)
Service/supplier (3)
Sickle cell disease (29)
Special edition (1)
Spinal muscular atrophy (9)
Sponsored (8)
Startups (285)
Stem cells (1)
Stomach cancer (1)
Supply chain (6)
Vaccines (70)
Venture capital (9)
Weight loss (5)
Wet AMD (1)
Women's health (4)
Date
Last 7 days (45)
Last 30 days (249)
Last 365 days (2052)
2026 (1871)
2025 (2135)
2024 (2660)
2023 (2944)
2022 (3982)
2021 (3707)
2020 (3240)
2019 (2625)
2018 (1999)
2017 (2114)
2016 (2129)
2015 (2373)
2014 (1612)
2013 (1399)
2012 (1395)
2011 (1458)
2010 (1360)
Location
Africa (48)
Alabama (3)
Alaska (1)
Arizona (17)
Arkansas (1)
Asia (2074)
Australia (443)
California (1365)
Canada (273)
China (128)
Colorado (52)
Connecticut (25)
Delaware (23)
Europe (6700)
Florida (143)
Georgia (5)
Idaho (2)
Illinois (150)
India (11)
Indiana (19)
Iowa (10)
Japan (44)
Kansas (2)
Kentucky (5)
Louisiana (3)
Maine (2)
Maryland (132)
Massachusetts (768)
Michigan (13)
Minnesota (9)
Missouri (9)
Nebraska (2)
Nevada (10)
New Hampshire (2)
New Jersey (274)
New Mexico (1)
New York (338)
North Carolina (167)
North Dakota (11)
Northern California (797)
Ohio (22)
Oklahoma (1)
Oregon (2)
Pennsylvania (238)
Rhode Island (8)
South America (58)
South Carolina (4)
Southern California (479)
Tennessee (25)
Texas (322)
United States (4240)
Utah (145)
Virginia (11)
Washington D.C. (2)
Washington State (74)
Wisconsin (43)
45,250 Results for "codex dna".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Funding
Seawolf surfaces with $100M, $1.2B Sanofi pact for redosable DNA medicines
Backed by Novartis’ venture arm, Eli Lilly and CRISPR Therapeutics, Seawolf is advancing its nonviral DNA delivery platform while inking a pact with Sanofi.
November 16, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
ProBio Sets New Standard in GMP Plasmid DNA Manufacturing with Guaranteed ≥ 85% Supercoiled DNA, Fixed-Cost, Clinical-Grade Delivered in Just 3 Months
November 1, 2026
·
4 min read
Press Releases
Seawolf Therapeutics Debuts With $100 Million to Advance DNA-Based Therapeutics
November 16, 2026
·
3 min read
Press Releases
Researchers Gain Faster Access to Complex DNA as Integrated DNA Technologies and Ansa Biotechnologies Expand Ordering Platform
September 1, 2026
·
6 min read
Press Releases
Feeding Mice Fewer Calories Reduces DNA Mutations
September 9, 2026
·
5 min read
Press Releases
HTL Biotechnology launches HTL8, a production unit dedicated to pharmaceutical-grade polynucleotides (DNA)
November 13, 2026
·
3 min read
Press Releases
Ansa Biotechnologies Raises $71.5 Million in Oversubscribed Series C Round to Scale Guaranteed DNA Synthesis
November 18, 2026
·
5 min read
Press Releases
Integrated DNA Technologies Defines the Next Era of DNA Synthesis: Full-Spectrum Capabilities for Speed, Complexity and Scale
August 20, 2026
·
5 min read
Press Releases
Integrated DNA Technologies and Aldevron Launch New mRNA Solutions to Simplify Base and Prime Editing
November 4, 2026
·
6 min read
Press Releases
Kane Biotech Announces Engagement of DNA Advisors
August 5, 2026
·
4 min read
1 of 4,525
Next